This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Biomerieux, Inc.. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: The Innovative Contributions of Laszlo Kondacs
Introduction
Laszlo Kondacs is a notable inventor based in Sunderland, GB. He has made significant contributions to the field of microbiology through his innovative research and development of antibacterial compounds. His work is particularly relevant in clinical diagnostics and health control.
Latest Patents
Kondacs holds a patent for an antibacterial compound, specifically designed to exhibit advantageous antibacterial properties. The structural formula of this compound is L-pyroglutamyl-L-1-aminoethyltetrazole, also known as N-(1-(1H-tetrazol-5-yl)ethyl)-5-oxopyrrolidine-2-carboxamide. This compound is utilized in microbiological culture methods and media aimed at the detection, identification, enrichment, counting, and isolation of target microorganisms. These microorganisms may be encountered in samples taken for clinical diagnosis or microbiological health control purposes.
Career Highlights
Kondacs has built a career at Biomerieux, Inc., where he has been able to apply his expertise in developing innovative solutions for health-related challenges. His work has been instrumental in advancing the field of microbiology and improving diagnostic methods.
Collaborations
Throughout his career, Kondacs has collaborated with notable colleagues, including Mark Gray and Rosaleen Anderson. These collaborations have further enhanced his research and contributed to the success of his projects.
Conclusion
Laszlo Kondacs is a distinguished inventor whose work in antibacterial compounds has made a significant impact in the field of microbiology. His innovative contributions continue to influence clinical diagnostics and health control practices.